CPI Aero falls 4% as fourth quarter revenue misses estimates

CPI Aerostructures reported Q4 revenue of $19.4M, down 11% YoY from $21.8M, and Q4 EPS of $0.05 versus $0.08 a year ago; shares fell ~4.34% pre-market. Full-year 2025 revenue was $69.3M (vs $81.1M in 2024) and the company posted a net loss of $0.8M (−$0.07/share) versus $3.3M net income in 2024. Management cited the A-10 program termination but noted contract wins (Raytheon, Lockheed, USAF, Sikorsky), a $505M backlog and a debt refinancing with Western Alliance Bank extending maturity to Dec 2030 and lowering the interest rate. Overall fundamentals weakened for 2025, though backlog and refinancing provide some balance to near-term liquidity concerns.

Analysis

The forced exit from a legacy program is less a one-off revenue hole and more a structural reset: skilled labor, tooling and supplier relationships tied to that program become stranded capacity that must be re-deployed or written down. That creates a 6–18 month margin compression window as the company retrains personnel and retools, even as new prime contracts begin to ramp; watch gross-margin trajectory and headcount/CapEx cadence for early signs of recovery.

Refinancing extends the runway but raises a second-order working-capital cadence risk: defense primes typically pay on milestone schedules, not steady monthly flow, so backlog conversion timing—not backlog size—drives near-term liquidity. Expect episodes of cash volatility around program milestones; the immediate liability pressure is manageable but covenant testing and interest-cost sensitivity remain meaningful if revenue ramps slip into the 12–24 month band.

Market reaction has likely over-indexed to small-cap execution fear while underweighting program-conversion optionality embedded in prime awards. The clearest near-term catalysts are (1) first revenue weeks from new prime work, (2) sequential margin stabilization, and (3) proof points of supplier requalification. Conversely, delays from primes, further program cancellations, or a tightening credit backdrop would flip the story quickly — monitor prime payment notices and bank covenant filings closely over the next two quarters.

Key Decisions for Investors

• Tactical long CVU equity (6–12 month horizon): allocate 0.5–1.0% of NAV. Rationale: asymmetric upside if backlog converts and margins normalize; execution risk is high so use a hard 25–30% stop. Target 2x upside (premium multiple rerating) if sequential revenue and margin beats arrive for two consecutive quarters.
• Defined-risk option spread on CVU (12 months): buy a 9–12 month OTM call spread (buy nearer-term upside, sell higher strike further-dated) sized to cost no more than 0.2% NAV. This captures re-rating upside while limiting capital at risk if conversion delays persist; pair by selling a single 1–3 month call against each spread to harvest premium on near-term pessimism.
• Paired idiosyncratic trade (6–12 months): long CVU / short LMT at 0.25x notional of the long. Use this to isolate CVU-specific execution improvement versus industry macro. If defense demand falls broadly, the short reduces systemic exposure; if CVU executes, pair should outperform materially.
• Sell put to acquire position on weakness (45–90 day bite): sell short-dated puts ~15–25% OTM to collect premium and establish an effective lower-cost basis. Cap assignment risk by sizing so maximum notional equals desired long exposure (do not exceed 1% NAV).